Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
EMHJ-Eastern Mediterranean Health Journal. 2004; 10 (3): 329-335
em Inglês | IMEMR | ID: emr-158291

RESUMO

We evaluated the COBAS AMPLICOR polymerase chain reaction [PCR] based test for the detection of Mycobacterium tuberculosis complex in 866 respiratory and non-respiratory samples. Acid-fast staining and culture on Lowenstein-Jensen medium were also performed on all samples. Of the 866 samples tested, 87 [10.0%] were PCR-positive compared to 94 [10.9%] culture positive. There were no false positive results but 7 PCR-negative, culture-positive samples were, considered false negatives after reviewing medical records of patients. A PCR inhibitory rate of 2.0% [17/866] was observed in respiratory samples only. Sensitivity, specificity, and positive and negative predictive values for this test were 92.5%, 100%, 100% and 99.1% respectively. This test is a valuable diagnostic tool for today's mycobacteriology laboratory


Assuntos
Humanos , Biópsia , Líquido da Lavagem Broncoalveolar/microbiologia , Técnicas de Cultura de Células/métodos , Líquido Cefalorraquidiano/microbiologia , Corantes , Reações Falso-Positivas , Sensibilidade e Especificidade , Tuberculose/diagnóstico
2.
EMHJ-Eastern Mediterranean Health Journal. 2002; 8 (4-5): 664-670
em Inglês | IMEMR | ID: emr-158106

RESUMO

All published material on the prevalence of drug-resistant tuberculosis within Saudi Arabia over the period 1979-98 was reviewed. The prevalence of single-drug-resistant tuberculosis ranged from 3.4% to 41% for isoniazid, 0% to 23.4% for rifampicin, 0.7% to 22.7% for streptomycin and 0% to 6.9% for ethambutol. The prevalence of multidrug-resistant tuberculosis [defined by WHO as resist1qance to two or more first-line antituberculosis drugs] ranged from 1.5% to 44% in different regions. No strong conclusions could be drawn owing to variations in the populations studied, geographical origins, site of Mycobacterium tuberculosis isolation [pulmonary or extrapulmonary] and drug sensitivity testing. However, the need to develop a standardized national policy for surveillance of drug-resistant tuberculosis in Saudi Arabia is clear


Assuntos
Humanos , Antituberculosos , Farmacorresistência Bacteriana Múltipla , Epidemiologia Molecular , Testes de Sensibilidade Microbiana , Vigilância da População , Prevalência , Projetos de Pesquisa/normas , Características de Residência/estatística & dados numéricos
3.
EMHJ-Eastern Mediterranean Health Journal. 2002; 8 (4-5): 654-663
em Inglês | IMEMR | ID: emr-158109

RESUMO

Although Saudi medical laboratories have developed enormously over the past 25 years, the absence of a national body for medical laboratory accreditation has meant the number of accredited laboratories [seven] remains low. Of these, five are accredited by the College of American Pathologists' Laboratory Accreditation Program [LAP]-the 'gold standard' of laboratory accreditation. It requires successful performance in the College of American Pathologists' proficiency testing programme as well as passing on-site inspections carried out by practising laboratory technicians, after which the laboratory is accredited for a 2-year period. This article gives an insight into the current situation of laboratory accreditation in Saudi Arabia and an updated overview of the process involved in obtaining laboratory accreditation from the College of American Pathologists


Assuntos
Humanos , Acreditação/organização & administração , Competência Clínica/normas , Honorários e Preços , Avaliação das Necessidades , Patologia Clínica/normas , Garantia da Qualidade dos Cuidados de Saúde/organização & administração , Sociedades Médicas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA